TP53 and anemia: In this study, intra-pulmonary delivery of shRNA targeting the p53-dependent lncRNA expression could decrease hemorrhage and improve anemia through reducing cell apoptosis in the lungs of a mouse model, implicating the therapeutic potential in clinical patients.